Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.

• Authors: R W Carlson, R D Williams, M E Billingham, M Kohler, F M Torti
• Journal: Cancer treatment reports (Cancer Treat Rep) 1987 Jul-Aug Vol. 71 Issue 7-8 Pg. 767-8 ISSN: 0361-5960 [Print] United States
• PMID: 3607787 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Doxorubicin
• esorubicin

Topics

• Adult
• Aged
• Blood Cell Count
• California
• Carcinoma (drug therapy, mortality)
• Doxorubicin (adverse effects, analogs & derivatives, therapeutic use)
• Drug Evaluation
• Humans
• Kidney Neoplasms (drug therapy, mortality)
• Middle Aged
• Neoplasm Metastasis